Mangoceuticals (MGRX) News Today $2.03 +0.02 (+1.00%) Closing price 06/13/2025 04:00 PM EasternExtended Trading$2.02 0.00 (-0.25%) As of 06/13/2025 07:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock MGRX Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Mangoceuticals Strengthens Position with Equity TransactionsJune 10, 2025 | tipranks.comMangoceuticals files to sell 4.46M shares of common stock by selling shareholdersMay 30, 2025 | msn.comMangoceuticals, Inc.: Mangoceuticals' Patented MGX-0024 Delivers 100% Respiratory Survival in Poultry Studies Signaling Strong Potential Defense Against Spread of Avian FluMay 29, 2025 | finanznachrichten.deMangoceuticals, Inc. Reports 100% Survival Rates in Field Studies of MGX-0024 for Poultry Respiratory DiseasesMay 29, 2025 | nasdaq.comMangoceuticals shares results from field studies on MGX-0024May 29, 2025 | finance.yahoo.comMangoceuticals' Patented MGX-0024 Delivers 100% Respiratory Survival in Poultry Studies Signaling Strong Potential Defense Against Spread of Avian FluMay 27, 2025 | globenewswire.comMangoceuticals, Inc. Terminates Agreements with Key PartnersMay 23, 2025 | tipranks.comMangoceuticals Enters Wellness Pouch Market, Appoints Tim Corkum To Lead New UnitApril 27, 2025 | nasdaq.comMangoceuticals enters into agreement to acquire assets of Smokeless TechnologyApril 27, 2025 | markets.businessinsider.comMangoceuticals Acquires IP to Expand Product LineApril 25, 2025 | tipranks.comMangoceuticals Announces Strategic Entry into High Growth Pouch Industry Through Acquisition of Smokeless Technology IP and Appointment of Tim Corkum Ex Philip Morris Executive to Lead High Growth Pouch DivisionApril 25, 2025 | globenewswire.comMangoceuticals Is Reengineering the Self-Care Blueprint with Better Personal Health and Wellness SolutionsApril 24, 2025 | finance.yahoo.comMangoceuticals Issues Bonus Shares to LeadershipApril 11, 2025 | tipranks.comMangoceuticals Issues Common Stock in Exchange for PreferredMarch 30, 2025 | investing.comMangoceuticals Announces Equity and Leadership ChangesMarch 21, 2025 | uk.investing.comMangoceuticals, Inc. Approves Key Amendments at Special MeetingMarch 19, 2025 | tipranks.comMangoceuticals launches PeachesRx women’s telehealth brandFebruary 21, 2025 | markets.businessinsider.comMangoceuticals Announces the Launch of “PeachesRx” - a Women's Telehealth Brand Focused on Personalized Wellness and GLP-1 Weight Loss TreatmentsFebruary 20, 2025 | uk.finance.yahoo.comMangoceuticals Advances Research on Respiratory Illness Prevention Technologies Targeting Avian InfluenzaFebruary 14, 2025 | nasdaq.comMangoceuticals advances research on patented respiratory illness technologyFebruary 12, 2025 | markets.businessinsider.comMangoceuticals targets avian flu with water-based solutionFebruary 12, 2025 | msn.comMangoceuticals Expands COO Role and Increases CompensationFebruary 7, 2025 | tipranks.comMangoceuticals advances H1N1 study conducted by VipragenFebruary 6, 2025 | markets.businessinsider.comMangoceuticals advances in H1N1 and H5N1 studiesFebruary 6, 2025 | msn.comMangoceuticals executes exclusive distribution agreement with PropreFebruary 4, 2025 | markets.businessinsider.comMangoceuticals, Inc. Executes Exclusive Distribution Agreement with Propre Energie for Clinically Proven Dermytol®️ Skincare Treatment Targeting HyperpigmentationFebruary 3, 2025 | globenewswire.comMangoceuticals, Inc. Finalizes Debt Conversion and AppointmentsJanuary 21, 2025 | tipranks.comMangoceuticals Expands with Patent Acquisition in NutraceuticalsDecember 20, 2024 | markets.businessinsider.comMangoceuticals, Inc. Completes Acquisition of Mushroom-Based Wellness and Innovations PatentDecember 19, 2024 | globenewswire.comMangoceuticals, Inc. (MGRX) Latest Stock News & Headlines - Yahoo FinanceDecember 6, 2024 | finance.yahoo.comMangoceuticals initiates investigation into potential stock manipulationDecember 5, 2024 | markets.businessinsider.comMangoceuticals Signs Consulting Deal with CFO JohnstonNovember 14, 2024 | markets.businessinsider.comMangoceuticals, Inc. Regains Full Compliance with Nasdaq Minimum Bid Price RequirementNovember 1, 2024 | markets.businessinsider.comMangoceuticals, Inc. (MGRX) Stock Price, News, Quote & History - Yahoo FinanceOctober 26, 2024 | ca.finance.yahoo.comMangoceuticals board initiates process to evaluate strategic alternativesOctober 22, 2024 | markets.businessinsider.comMangoceuticals, Inc.: MangoRx Responds to and Refutes Recent Claims Made by Eli LillyOctober 22, 2024 | finanznachrichten.deMangoceuticals Defends Against Eli Lilly AllegationsOctober 22, 2024 | markets.businessinsider.comMangoceuticals refutes claims made by Lilly in weight-loss drug lawsuitOctober 22, 2024 | seekingalpha.comMangoRx Announces Formation of Strategy and Alternatives CommitteeOctober 22, 2024 | finance.yahoo.comMangoceuticals Opts For Strategic AlternativesOctober 22, 2024 | markets.businessinsider.comMangoRx Responds to and Refutes Recent Claims Made by Eli LillyOctober 21, 2024 | globenewswire.comStock Splits Do Matter and Here's What's Coming NextOctober 16, 2024 | 247wallst.comMangoceuticals announces 1-for-15 reverse stock splitOctober 13, 2024 | finance.yahoo.comMANGOCEUTICALS, INC. ANNOUNCES 1-FOR 15 REVERSE STOCK SPLIT AS PART OF NASDAQ COMPLIANCE PLANOctober 11, 2024 | finance.yahoo.comMANGOCEUTICALS, INC. ANNOUNCES 1-FOR 15 REVERSE STOCK SPLIT AS PART OF NASDAQ COMPLIANCE PLANOctober 11, 2024 | globenewswire.comMangoRx Introduces Oral Tirzepatide GLP-1 Receptor Agonist for Advanced Weight Loss SolutionsOctober 3, 2024 | globenewswire.comShares of Healthcare Company Rise Following Product Availability AnnouncementOctober 1, 2024 | msn.comHealthcare Shares Rise Following Product Availability AnnouncementOctober 1, 2024 | theglobeandmail.comMangoRx Addresses $49.3 Billion Global GLP-1 Market With Launch of Oral Semaglutide for Advanced Weight Loss TreatmentOctober 1, 2024 | finance.yahoo.comMangoRx Addresses $49.3 Billion Global GLP-1 Market With Launch of Oral Semaglutide for Advanced Weight Loss TreatmentOctober 1, 2024 | globenewswire.com Get Mangoceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for MGRX and its competitors with MarketBeat's FREE daily newsletter. Email Address MGRX Media Mentions By Week MGRX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MGRX News Sentiment▼0.790.89▲Average Medical News Sentiment MGRX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MGRX Articles This Week▼31▲MGRX Articles Average Week Get Mangoceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for MGRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies BNR News CCM News MRAI News ENZ News BRTX News SSY News OTRK News BGLC News ATIP News VSEE News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MGRX) was last updated on 6/15/2025 by MarketBeat.com Staff From Our PartnersAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredWe’ve Entered the Most Bullish Phase of the CycleIt happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAIEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredCollect $7k per month from Tesla’s SECRET dividendI just uncovered a strategy that could pay out up to $7,013 every month—without needing a traditional dividend...Investors Alley | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mangoceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Mangoceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MGRX Stock Free MGRX Stock Alerts